|
US10704021B2
(en)
|
2012-03-15 |
2020-07-07 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US9745548B2
(en)
|
2012-03-15 |
2017-08-29 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US10322949B2
(en)
|
2012-03-15 |
2019-06-18 |
Flodesign Sonics, Inc. |
Transducer and reflector configurations for an acoustophoretic device
|
|
US10689609B2
(en)
|
2012-03-15 |
2020-06-23 |
Flodesign Sonics, Inc. |
Acoustic bioreactor processes
|
|
US9752113B2
(en)
|
2012-03-15 |
2017-09-05 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US9458450B2
(en)
|
2012-03-15 |
2016-10-04 |
Flodesign Sonics, Inc. |
Acoustophoretic separation technology using multi-dimensional standing waves
|
|
US9950282B2
(en)
|
2012-03-15 |
2018-04-24 |
Flodesign Sonics, Inc. |
Electronic configuration and control for acoustic standing wave generation
|
|
US10967298B2
(en)
|
2012-03-15 |
2021-04-06 |
Flodesign Sonics, Inc. |
Driver and control for variable impedence load
|
|
US10737953B2
(en)
|
2012-04-20 |
2020-08-11 |
Flodesign Sonics, Inc. |
Acoustophoretic method for use in bioreactors
|
|
WO2014100615A1
(en)
|
2012-12-20 |
2014-06-26 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
ES2828982T3
(es)
|
2013-05-14 |
2021-05-28 |
Univ Texas |
Aplicación humana de células t de receptor de antígeno quimérico (car) diseñadas
|
|
WO2014190273A1
(en)
|
2013-05-24 |
2014-11-27 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor-targeting monoclonal antibodies
|
|
US9745569B2
(en)
|
2013-09-13 |
2017-08-29 |
Flodesign Sonics, Inc. |
System for generating high concentration factors for low cell density suspensions
|
|
US9725710B2
(en)
|
2014-01-08 |
2017-08-08 |
Flodesign Sonics, Inc. |
Acoustophoresis device with dual acoustophoretic chamber
|
|
CA3190002A1
(en)
|
2014-02-14 |
2015-08-20 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors and methods of making
|
|
AU2015249554B2
(en)
|
2014-04-23 |
2021-08-19 |
Juno Therapeutics, Inc. |
Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
|
|
US9744483B2
(en)
|
2014-07-02 |
2017-08-29 |
Flodesign Sonics, Inc. |
Large scale acoustic separation device
|
|
GB201506423D0
(en)
|
2015-04-15 |
2015-05-27 |
Tc Biopharm Ltd |
Gamma delta T cells and uses thereof
|
|
FR3026744B1
(fr)
|
2014-10-06 |
2024-04-19 |
Hopitaux Paris Assist Publique |
Methode de generation de progeniteurs de cellules t
|
|
EP3215534B1
(en)
|
2014-11-05 |
2020-04-15 |
Board of Regents, The University of Texas System |
Chimeric antigen receptors (car) to selectively target protein complexes
|
|
SI3240805T1
(sl)
|
2014-12-15 |
2025-04-30 |
The Regents Of The University Of California |
Bispecifični or-gate himerni antigenski receptor, odziv na cd19 in cd20
|
|
CN107667169B
(zh)
|
2015-02-24 |
2021-10-29 |
得克萨斯州大学系统董事会 |
遗传修饰的t细胞的选择方法
|
|
KR102615825B1
(ko)
|
2015-03-11 |
2023-12-21 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
전위효소 폴리펩타이드 및 이의 용도
|
|
US11021699B2
(en)
|
2015-04-29 |
2021-06-01 |
FioDesign Sonics, Inc. |
Separation using angled acoustic waves
|
|
US11377651B2
(en)
|
2016-10-19 |
2022-07-05 |
Flodesign Sonics, Inc. |
Cell therapy processes utilizing acoustophoresis
|
|
US11708572B2
(en)
|
2015-04-29 |
2023-07-25 |
Flodesign Sonics, Inc. |
Acoustic cell separation techniques and processes
|
|
GB201507368D0
(en)
*
|
2015-04-30 |
2015-06-17 |
Ucl Business Plc |
Cell
|
|
US11474085B2
(en)
|
2015-07-28 |
2022-10-18 |
Flodesign Sonics, Inc. |
Expanded bed affinity selection
|
|
US11459540B2
(en)
|
2015-07-28 |
2022-10-04 |
Flodesign Sonics, Inc. |
Expanded bed affinity selection
|
|
WO2017023803A1
(en)
|
2015-07-31 |
2017-02-09 |
Regents Of The University Of Minnesota |
Modified cells and methods of therapy
|
|
EP3328994A4
(en)
*
|
2015-07-31 |
2019-04-17 |
Memorial Sloan-Kettering Cancer Center |
CD56-Faced Antigen-Binding Proteins and Uses Thereof
|
|
EP3349791A1
(en)
|
2015-09-15 |
2018-07-25 |
Board of Regents, The University of Texas System |
T-cell receptor (tcr)-binding antibodies and uses thereof
|
|
US11059879B2
(en)
|
2015-10-27 |
2021-07-13 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor molecules and uses thereof
|
|
EP4074731A1
(en)
*
|
2015-11-04 |
2022-10-19 |
City of Hope |
Chimeric antigen receptors targeting her2
|
|
MX2018005825A
(es)
*
|
2015-11-09 |
2019-07-04 |
Aperisys Inc |
Celulas inmunes modificadas y usos de las mismas.
|
|
EP3407919A4
(en)
*
|
2016-01-28 |
2019-09-04 |
The Regents of the University of California |
METHOD FOR THE SELECTIVE EXPANSION AND ENRICHMENT OF CELLS TRANSDUCED WITH CHIMERIC ANTIGEN RECEPTORS AND TREATMENT OF HIV INFECTION
|
|
AU2017213661B2
(en)
*
|
2016-02-05 |
2022-06-02 |
City Of Hope |
Administration of engineered T cells for treatment of cancers in the central nervous system
|
|
US12144850B2
(en)
|
2016-04-08 |
2024-11-19 |
Purdue Research Foundation |
Methods and compositions for car T cell therapy
|
|
US20190119758A1
(en)
*
|
2016-04-22 |
2019-04-25 |
Kura Oncology, Inc. |
Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors
|
|
US11214789B2
(en)
|
2016-05-03 |
2022-01-04 |
Flodesign Sonics, Inc. |
Concentration and washing of particles with acoustics
|
|
US11085035B2
(en)
|
2016-05-03 |
2021-08-10 |
Flodesign Sonics, Inc. |
Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
|
|
KR102522419B1
(ko)
|
2016-06-06 |
2023-04-17 |
시티 오브 호프 |
Baff-r 표적 키메라 항원 수용체-변형된 t 세포 및 그 용도
|
|
WO2017214569A1
(en)
*
|
2016-06-09 |
2017-12-14 |
Regents Of The University Of Minnesota |
Genome-edited nk cell and methods of making and using
|
|
CN107523547A
(zh)
*
|
2016-06-20 |
2017-12-29 |
上海细胞治疗研究院 |
一种高效稳定表达抑制性抗体的car‑t细胞及其用途
|
|
US11583555B2
(en)
|
2016-06-24 |
2023-02-21 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Genetic re-engineering of immune cells to improve metabolic fitness for immunotherapy
|
|
CN107663240B
(zh)
*
|
2016-07-29 |
2021-01-12 |
中国人民解放军第四军医大学 |
高度糖基化cea特异性结合的单链抗体及其在检测和治疗上的应用
|
|
AU2017319151B2
(en)
|
2016-08-30 |
2024-01-11 |
Memorial Sloan Kettering Cancer Center |
Immune cell compositions and methods of use for treating viral and other infections
|
|
JP2020513248A
(ja)
|
2016-10-19 |
2020-05-14 |
フロデザイン ソニックス， インク．Ｆｌｏｄｅｓｉｇｎ Ｓｏｎｉｃｓ， Ｉｎｃ． |
音響による親和性細胞抽出
|
|
AU2017384900B2
(en)
|
2016-12-28 |
2020-12-10 |
GC Cell Corporation |
Chimeric antigen receptor and natural killer cells expressing same
|
|
AU2018217404B2
(en)
|
2017-02-13 |
2024-03-28 |
Assistance Publique - Hopitaux De Paris |
Method for generating T cells progenitors
|
|
ES3010559T3
(en)
|
2017-02-28 |
2025-04-03 |
Endocyte Inc |
Compositions and methods for car t cell therapy
|
|
US11629340B2
(en)
|
2017-03-03 |
2023-04-18 |
Obsidian Therapeutics, Inc. |
DHFR tunable protein regulation
|
|
US11166985B2
(en)
|
2017-05-12 |
2021-11-09 |
Crispr Therapeutics Ag |
Materials and methods for engineering cells and uses thereof in immuno-oncology
|
|
JP7356354B2
(ja)
|
2017-05-12 |
2023-10-04 |
クリスパー セラピューティクス アクチェンゲゼルシャフト |
細胞の操作のための材料及び方法並びに免疫腫瘍学におけるその使用
|
|
CN107099603A
(zh)
*
|
2017-05-31 |
2017-08-29 |
成都克里斯博生物科技有限公司 |
肿瘤免疫t细胞检测试剂盒和检测方法
|
|
GB201709203D0
(en)
*
|
2017-06-09 |
2017-07-26 |
Autolus Ltd |
Antigen-binding domain
|
|
JP7210534B2
(ja)
*
|
2017-07-12 |
2023-01-23 |
ザ・ボード・オブ・トラスティーズ・オブ・ザ・リーランド・スタンフォード・ジュニア・ユニバーシティ |
Ｈ３ｋ２７ｍ変異を有するがんの処置のための組成物および方法
|
|
EP3658163A4
(en)
*
|
2017-07-25 |
2021-08-04 |
Board Of Regents, The University Of Texas System |
IMPROVED ANTIGENIC CHEMICAL RECEPTORS AND THEIR USES
|
|
TWI676483B
(zh)
*
|
2017-08-06 |
2019-11-11 |
強普生技股份有限公司 |
醫藥套組及其用途
|
|
CN107287165A
(zh)
*
|
2017-08-23 |
2017-10-24 |
湖南开启时代生物科技有限责任公司 |
一种car‑t细胞的制备方法
|
|
WO2019047932A1
(zh)
*
|
2017-09-08 |
2019-03-14 |
科济生物医药（上海）有限公司 |
基因工程化的t细胞及应用
|
|
MX421596B
(es)
*
|
2017-09-29 |
2025-03-14 |
Us Health |
Receptores de celulas t que reconocen p53 mutado
|
|
CN107488738B
(zh)
*
|
2017-10-12 |
2020-04-28 |
中国医学科学院肿瘤医院 |
一种预测乳腺癌对曲妥珠单抗联合化疗治疗敏感性的生物标志物
|
|
US11649294B2
(en)
|
2017-11-14 |
2023-05-16 |
GC Cell Corporation |
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
|
|
CN111655732B
(zh)
|
2017-11-14 |
2023-09-12 |
Gc细胞治疗 |
抗her2抗体或其抗原结合片段及包含其的嵌合抗原受体
|
|
JP7517983B2
(ja)
*
|
2017-11-20 |
2024-07-17 |
ユリウス－マクシミリアン－ウニヴェルシテート・ヴュルツブルク |
非常に低レベルのｃｄ１９を発現する骨髄腫細胞を除去するｃｄ１９ｃａｒｔ細胞
|
|
CU24558B1
(es)
*
|
2017-11-28 |
2021-12-08 |
Ct Inmunologia Molecular |
Anticuerpos monoclonales que reconocen al receptor del factor de crecimiento epidérmico y sus fragmentos derivados
|
|
CN108070033A
(zh)
*
|
2017-12-12 |
2018-05-25 |
武汉波睿达生物科技有限公司 |
一种3bnc-car分子的构建及其在杀灭hiv-1感染细胞中的应用
|
|
US10785574B2
(en)
|
2017-12-14 |
2020-09-22 |
Flodesign Sonics, Inc. |
Acoustic transducer driver and controller
|
|
JP7505761B2
(ja)
|
2017-12-15 |
2024-06-25 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
Ｔ細胞疲弊を阻害するための組成物および方法
|
|
MY202687A
(en)
|
2017-12-23 |
2024-05-15 |
Uwell Biopharma Inc |
Pharmaceutical chimeric receptor composition and method thereof
|
|
US12491153B2
(en)
|
2018-01-03 |
2025-12-09 |
Qu Biologics Inc. |
Innate targeting of adoptive cellular therapies
|
|
US11965191B2
(en)
|
2018-01-18 |
2024-04-23 |
California Institute Of Technology |
Programmable protein circuits in living cells
|
|
JP7549303B2
(ja)
*
|
2018-01-22 |
2024-09-11 |
エンドサイト・インコーポレイテッド |
Ｃａｒ ｔ細胞の使用方法
|
|
WO2019147604A2
(en)
*
|
2018-01-23 |
2019-08-01 |
Vanderbilt University |
Self-antigen specific t-cells as vacines for augmenting engraftment and stability of autologous transfer
|
|
CN111936518A
(zh)
|
2018-02-06 |
2020-11-13 |
西雅图儿童医院（Dba西雅图儿童研究所） |
对fl-ple标记的肿瘤表现出最佳的t细胞功能的荧光素特异性car
|
|
CN112105382A
(zh)
|
2018-02-23 |
2020-12-18 |
恩多塞特公司 |
用于car t细胞疗法的顺序方法
|
|
CN112105723A
(zh)
*
|
2018-03-08 |
2020-12-18 |
鲁比厄斯治疗法股份有限公司 |
用于治疗癌症和传染病的治疗性细胞系统和方法
|
|
US20190247437A1
(en)
*
|
2018-04-19 |
2019-08-15 |
APDN (B.V.I.), Inc. |
Engineered lymphocyte compositions, methods and systems
|
|
EP3790629A1
(en)
|
2018-05-11 |
2021-03-17 |
CRISPR Therapeutics AG |
Methods and compositions for treating cancer
|
|
SG11202100208VA
(en)
|
2018-07-09 |
2021-02-25 |
Precigen Inc |
Fusion constructs and methods of using thereof
|
|
JP7623935B2
(ja)
*
|
2018-08-07 |
2025-01-29 |
パーデュー・リサーチ・ファウンデーション |
Ｃａｒ ｔ細胞の若返り
|
|
CN110862967A
(zh)
*
|
2018-08-27 |
2020-03-06 |
天津天锐生物科技有限公司 |
一种不依赖细胞因子培养的自然杀伤细胞系silk-nk
|
|
US11542305B2
(en)
|
2018-08-31 |
2023-01-03 |
California Institute Of Technology |
Synthetic protein circuits detecting signal transducer activity
|
|
CN112888786A
(zh)
*
|
2018-09-07 |
2021-06-01 |
Sotio有限责任公司 |
与调节细胞内乳酸浓度的反式代谢分子组合的嵌合受体多肽及其治疗用途
|
|
CA3109747A1
(en)
*
|
2018-10-05 |
2020-04-09 |
St. Anna Kinderkrebsforschung |
A group of chimeric antigen receptors (cars)
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
EP3908653A4
(en)
|
2019-01-10 |
2022-11-02 |
California Institute of Technology |
A synthetic system for tunable thresholding of protein signals
|
|
SG11202108039QA
(en)
*
|
2019-01-25 |
2021-08-30 |
Univ Pennsylvania |
Compositions and methods for targeting mutant ras
|
|
WO2020163682A1
(en)
*
|
2019-02-07 |
2020-08-13 |
Board Of Regents, The University Of Texas System |
Glucuronoxylomannan (gxm) receptor chimeric antigen receptors and use thereof
|
|
CA3129100A1
(en)
*
|
2019-02-08 |
2020-08-13 |
Biontech Cell & Gene Therapies Gmbh |
Treatment involving car-engineered t cells and cytokines
|
|
PH12021552003A1
(en)
|
2019-02-15 |
2022-12-05 |
Editas Medicine Inc |
Modified natural killer (nk) cells for immunotherapy
|
|
CN118546959A
(zh)
|
2019-03-05 |
2024-08-27 |
恩卡尔塔公司 |
Cd19定向性嵌合抗原受体及其在免疫疗法中的用途
|
|
CN113939319A
(zh)
|
2019-04-30 |
2022-01-14 |
克里斯珀医疗股份公司 |
靶向cd19的基因工程化t细胞针对b细胞恶性肿瘤的同种异体细胞疗法
|
|
AU2020287882A1
(en)
*
|
2019-06-07 |
2022-01-20 |
Juno Therapeutics, Inc. |
Automated T cell culture
|
|
EP3980453A4
(en)
*
|
2019-06-07 |
2023-07-05 |
The Trustees of the University of Pennsylvania |
Dual car expressing t cells individually linked to cd28 and 4-1bb
|
|
EP4028413A1
(en)
|
2019-09-10 |
2022-07-20 |
Obsidian Therapeutics, Inc. |
Ca2-il15 fusion proteins for tunable regulation
|
|
CA3156191A1
(en)
*
|
2019-11-06 |
2021-05-14 |
Vanaja KONDURI |
Method for producing cytotoxic effector memory t cells for t-cell treatment of cancer
|
|
KR20220128988A
(ko)
*
|
2019-11-27 |
2022-09-22 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
항-cd3 scfv 및 사이토카인 생산용 인공 항원 제시 세포
|
|
IL293716A
(en)
*
|
2019-12-11 |
2022-08-01 |
A2 Biotherapeutics Inc |
Lilrb1-based chimeric antigen receptor
|
|
GB2609103A
(en)
*
|
2020-02-25 |
2023-01-25 |
Quell Therapeutics Ltd |
Chimeric receptors for use in engineered cells
|
|
CN111253493B
(zh)
*
|
2020-03-05 |
2021-03-23 |
武汉科技大学 |
一种靶向hiv病毒囊膜双位点的嵌合抗原受体及其表达载体和应用
|
|
US12264190B2
(en)
*
|
2020-04-24 |
2025-04-01 |
Astrazeneca Ab |
Compositions and methods of treating cancer with chimeric antigen receptors
|
|
WO2022011256A1
(en)
|
2020-07-10 |
2022-01-13 |
Precigen, Inc. |
Fusion constructs and methods of using thereof
|
|
CN114716548B
(zh)
*
|
2021-01-05 |
2024-11-05 |
(株)爱恩德生物 |
抗-fgfr3抗体及其用途
|
|
US20240327889A1
(en)
*
|
2021-04-05 |
2024-10-03 |
Victor TETS |
Regulation of cells and organisms
|
|
WO2022216813A1
(en)
*
|
2021-04-08 |
2022-10-13 |
Artiva Biotherapeutics, Inc. |
Chimeric antigen receptor comprising an anti-her2 antibody or antigen-binding fragment thereof and natural killer cells comprising the same
|
|
US20240293543A1
(en)
|
2021-06-23 |
2024-09-05 |
Editas Medicine, Inc. |
Engineered cells for therapy
|
|
CA3226947A1
(en)
|
2021-08-03 |
2023-02-09 |
Muhammad YASSIN |
Engineered tcr complex and methods of using same
|
|
EP4130028A1
(en)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Engineered tcr complex and methods of using same
|
|
EP4388017A1
(en)
*
|
2021-08-20 |
2024-06-26 |
Christopher E. Rudd |
Compositions and methods for anti-virus chimeric antigen receptor
|
|
US20250222029A1
(en)
*
|
2022-04-08 |
2025-07-10 |
Fate Therapeutics, Inc. |
Chimeric antigen receptor for tumor targeting
|
|
CN119256075A
(zh)
|
2022-04-08 |
2025-01-03 |
菲特治疗公司 |
具有实体瘤靶向骨架的细胞及其用途
|
|
CN115873803B
(zh)
*
|
2022-11-28 |
2025-06-17 |
上海恩凯细胞技术有限公司 |
提高nk细胞存活和抗肿瘤活性的方法及应用
|
|
US20250152743A1
(en)
*
|
2023-11-13 |
2025-05-15 |
California Institute Of Technology |
Synpoptosis circuits for programmable cell death control
|